We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKR icon
3651
Ark Restaurants
ARKR
$20.2M
$2K ﹤0.01%
+115
New +$2.32K
AVTR icon
3652
Avantor
AVTR
$9.19B
$2K ﹤0.01%
157
-9,220
-98% -$156K
AVXL icon
3653
Anavex Life Sciences
AVXL
$310M
$2K ﹤0.01%
689
-5,954
-90% -$17.2K
AWF
3654
AllianceBernstein Global High Income Fund
AWF
$872M
$2K ﹤0.01%
+200
New +$2.37K
BCLI
3655
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2K ﹤0.01%
+43
New +$2.54K
BLBD icon
3656
Blue Bird Corp
BLBD
$2.18B
$2K ﹤0.01%
+100
New +$1.91K
BROG
3657
DELISTED
Brooge Energy
BROG
$2K ﹤0.01%
+198
New +$2.02K
CBZ icon
3658
CBIZ
CBZ
$2.96B
$2K ﹤0.01%
72
-18,433
-100% -$414K
CEPU
3659
Central Puerto
CEPU
$2.1B
$2K ﹤0.01%
+837
New +$4.93K
CGO
3660
Calamos Global Total Return Fund
CGO
$130M
$2K ﹤0.01%
+156
New +$1.96K
CHMG icon
3661
Chemung Financial Corp
CHMG
$392M
$2K ﹤0.01%
+53
New +$2.32K
CMCO icon
3662
Columbus McKinnon
CMCO
$584M
$2K ﹤0.01%
54
-326
-86% -$12.1K
CPHC icon
3663
Canterbury Park Holding Corp
CPHC
$80M
$2K ﹤0.01%
154
-217
-58% -$2.68K
CRSP icon
3664
CRISPR Therapeutics
CRSP
$5.17B
$2K ﹤0.01%
47
-241
-84% -$11.5K
CYTK icon
3665
Cytokinetics
CYTK
$10.4B
$2K ﹤0.01%
+140
New +$1.76K
DJP icon
3666
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$794M
$2K ﹤0.01%
+92
New +$2.02K
DKL icon
3667
Delek Logistics
DKL
$3.02B
$2K ﹤0.01%
+66
New +$2.07K
DX
3668
Dynex Capital
DX
$3.21B
$2K ﹤0.01%
+128
New +$2K
EBMT icon
3669
Eagle Bancorp Montana
EBMT
$190M
$2K ﹤0.01%
102
-497
-83% -$8.32K
EFSC icon
3670
Enterprise Financial Services Corp
EFSC
$2.39B
$2K ﹤0.01%
57
-171
-75% -$6.89K
EMB icon
3671
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$2K ﹤0.01%
18
+1
+6% +$114
EPV icon
3672
ProShares UltraShort FTSE Europe
EPV
$10.1M
$2K ﹤0.01%
+10
New +$1.6K
EVC icon
3673
Entravision Communication
EVC
$1.1B
$2K ﹤0.01%
489
-552
-53% -$1.74K
EXTR icon
3674
Extreme Networks
EXTR
$3.15B
$2K ﹤0.01%
255
-682
-73% -$4.93K
FBNC icon
3675
First Bancorp
FBNC
$2.68B
$2K ﹤0.01%
+57
New +$2.04K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.